Leukemia Research
Volume 23, Issue 8 , Pages 709-718 , August 1999

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission

  • Robert Peter Gale

      Affiliations

    • Salick Health Care, Inc., 8201 Beverly Boulevard, Los Angeles, CA 90048-4520, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-213-9663496; fax: +1-213-9663490
    • ,
  • Rolla Edward Park

      Affiliations

    • RAND, Santa Monica, CA, USA
    • ,
  • Robert W. Dubois

      Affiliations

    • Value Health Sciences, Santa Monica, CA, USA
    • ,
  • Geoffrey P. Herzig

      Affiliations

    • Saint Vincent’s Comprehensive Cancer Center, New York, NY, USA
    • ,
  • William G. Hocking

      Affiliations

    • Marshfield Clinic, Marshfield, WI, USA
    • ,
  • Mary M. Horowitz

      Affiliations

    • Medical College of Wisconsin, Milwaukee, WI, USA
    • ,
  • Armand Keating

      Affiliations

    • Toronto General Hospital, Toronto Ont., Canada
    • ,
  • Sanford Kempin

      Affiliations

    • Desert Comprehensive Cancer Center, Palm Springs, CA, USA
    • ,
  • Charles A. Linker

      Affiliations

    • University of California, San Francisco, CA, USA
    • ,
  • Charles A. Schiffer

      Affiliations

    • Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA
    • ,
  • Peter H. Wiernik

      Affiliations

    • Albert Einstein Cancer Center, Bronx, NY, USA
    • ,
  • Daniel J. Weisdorf

      Affiliations

    • University of Minnesota, Minneapolis, MN, USA
    • ,
  • Kanti R. Rai

      Affiliations

    • Long Island Jewish Medical Center, New Hyde Park, NY, USA

Received 22 July 1998 ,Accepted 19 October 1998.

References 

  1. Lowenberg B. Post-remission treatment of acute myelogenous leukemia. New Engl. J. Med. 1995;332:260
  2. Clift RA, Buckner CD. Marrow transplantation for acute myeloid leukemia. Cancer Invest. 1998;16:53–61
  3. Passweg JR, Rowlings PA, Armitage JO, et al.  Report from the international Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry—North America. In:  Cecka JM,  Teraski PI editor. Clinical Transplants, 1995. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1996;p. 127–177
  4. Wolin MJ, Gale RP. Therapy of acute myelogenous leukemia: understanding the question, understanding the answer. Leuk. Res. 1997;21:3–8
  5. Burnett AK, Goldstone AH, Stevens RM, et al.  Randomized comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet. 1998;351:700–708
  6. Gale RP, Buchner T, Zhang M-J, et al.  HLA-identical sibling bone marrow transplants vs. chemotherapy for acute myelogenous leukemia in first remission. Leukemia. 1996;10:1687–1691
  7. Keating A, Rowlings PA, Zhang M-J, et al. Results of HLA-identical siblings and autologous bone marrow transplants for acute myelogenous leukemia in first remission. (submitted).
  8. Zittoun R, Mandelli F, Willenze R, et al.  Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl. J. Med. 1995;332:217
  9. Harousseau J-L, Cahn J-Y, Pignon B, et al.  Comparison of autologous bone marrow transplantation and intensive therapy in adult acute myeloid leukemia. Blood. 1997;90:2978–2986
  10. Brook RH, Chassin MR, Fink A, et al.  A method for the detailed assessment of the appropriateness of medical technologies. Int. J. Tech. Assess. Health Care. 1986;2:53–56
  11. Jones J, Hunter D. Consensus methods for medical and health services research. Br. Med. J. 1986;311:376–380
  12. Woolf SH. Practice guidelines, a new reality in medicine, I: recent developments; and II: methods of developing guidelines. Arch Intern Med 1990;150:1811–8; 1992;152:946–52.
  13. Park RE, Fink A, Brook RH, et al.  Physician ratings of appropriate indications for six medical and surgical procedures. Am. J. Publ. Health. 1986;76:766–772
  14. Gale RP, Park RE, Dubois R, et al. Delphi-consensus panel analysis of appropriateness of high-dose therapy and bone marrow transplants in acute lymphoblastic leukemia in 1st remission. Leuk Res 1998;22:973–81.
  15. Breiman L, Friedman JH, Olshen RA, et al.  In: Classification and regression trees. Monterey, CA: Wadsworth and Brooks; 1984;p. 75–78
  16. Shekelle PG, Chassin MR, Park RE. Evidence for the validity of criteria for performing carotoid endarterectomy. Int J Tech Assessment in Health Care 1998;14:707–27.
  17. Kravitz RL, Laouri M, Kahan JP, et al.  Validity of criteria used for detecting underuse of coronary revascularization. J. Am. Med. Ass. 1995;274:632–638
  18. Selby JVB, Fireman BH, Lundstrom RJ, et al.  Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. New Engl. J. Med. 1996;335:1888–1896
  19. Shekelle PG, Kahan JP, Bernstein SJ, et al.  Reproducibility of the method to identify the overuse and underuse of medical procedures. New Engl. J. Med. 1998;338:1888–1895

PII: S0145-2126(99)00044-2

Leukemia Research
Volume 23, Issue 8 , Pages 709-718 , August 1999

Article Tools

* Image Usage & Resolution